首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

市場調查報告書

商品編碼

1623153

全球基因組學市場規模（按技術、應用、產品/服務、地區、範圍和預測）

Global Genomics Market Size By Technology (Sequencing Technologies, Microarray Analysis), By Application (Diagnostics, Drug Discovery And Development), By Product And Services (Instruments And Equipment, Consumables), By Geographic Scope and Forecast

出版日期: 2024年11月04日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

基因體學市場規模及預測

基因組學市場規模預計在 2023 年達到 447.1 億美元，預計在 2024 年至 2031 年期間的複合年增長率為 18.90%，到 2031 年將達到 1584.5 億美元。全球基因組學是指對生物體整個基因組成進行全面研究和分析，包括其 DNA 序列、基因功能和相互作用。它在個人化醫療、農業和生物技術等領域中發揮著重要作用。在醫療保健領域，基因組學可以根據個人的基因特徵進行精準治療，改善癌症和遺傳性疾病等疾病的治療效果。在農業領域，基因編輯可以使作物更有彈性、更高產量。

在人工智慧和數據分析創新的推動下，全球基因組學的未來有望推動基因治療、藥物發現和永續農業的進步。

全球基因體學市場動態

主要市場驅動因子

個人化醫療需求不斷成長：

個人化醫療的日益普及是一個主要推動因素，個人化醫療是根據個人的基因特徵制定治療方案。根據美國國立衛生研究院的數據，2022 年批准的藥物中約有 39% 將是個人化療法。

基因體定序的技術進步：

下一代定序（NGS）等定序技術的不斷創新，大大降低了基因組定序的成本。美國國家人類基因組研究所報告稱，到2022年，人類基因組定序成本將從2001年的1億美元降至1,000美元以下。

政府資助與研究計畫：

世界各國政府都在投資基因組研究。例如，美國政府已於2023年為國家人類基因組研究所撥款6億美元，以支持基因體學研究的進步。

遺傳疾病發生率不斷上升：

癌症和罕見疾病等遺傳疾病和病症的增加推動了對基因組研究的需求。世界衛生組織 (WHO) 估計，大約 10% 的出生受到遺傳或部分遺傳疾病的影響，這推動了對基因組診斷和治療的需求。

主要問題

基因組技術成本高：

儘管取得了進展，但全基因組定序和數據分析等先進基因組技術的成本仍然很高，限制了它們的普及，尤其是在中低收入國家。

資料隱私與道德問題：

敏感遺傳資訊的儲存和分享引發了人們對隱私和濫用的擔憂，並存在歧視和未經授權存取個人健康資料的潛在風險。

解釋基因組數據的複雜性：

基因組數據龐大且複雜，對準確解釋研究結果提出了課題，並且需要先進的計算工具和尚未廣泛普及的專業知識。

監管和標準化問題：

全球基因組學市場面臨不同地區不同的監管框架，缺乏標準化協議可能會減緩基因組技術在臨床和研究環境中的採用。

主要趨勢：

整合人工智慧（AI）與機器學習：

人工智慧和機器學習越來越多地被用於分析大量基因組數據，提高準確性並加速疾病診斷和藥物開發等領域的發現。

直接面向消費者的基因體學的擴展：

越來越多的上市公司提供直接面向消費者的基因組測試，使個人能夠出於健康、家譜和保健目的獲取自己的基因信息，從而增加人們對基因組學的興趣。

擴大精準醫療計畫：

政府和醫療保健系統越來越重視精準醫療，它利用基因組學開發針對每個患者的基因特徵的個人化治療，特別是在癌症治療方面。

CRISPR 與基因編輯的進展：

基因編輯技術，尤其是 CRISPR，透過提供精確修改基因的工具，正在徹底改變基因組學領域，為基因治療、農業和生物技術開闢新的可能性。

Genomics Market size was valued at USD 44.71 Billion in 2023 and is projected to reach USD 158.45 Billion by 2031 , growing at a CAGR of 18.90% from 2024 to 2031. Global genomics refers to the comprehensive study and analysis of an organism's entire genetic makeup, including its DNA sequence, gene functions, and interactions. It plays a crucial role in fields such as personalized medicine, agriculture, and biotechnology. In healthcare, genomics enables precision treatments by tailoring therapies to an individual's genetic profile, improving outcomes for diseases like cancer and genetic disorders. In agriculture, it enhances crop resilience and productivity through gene editing.

The future of global genomics promises advancements in gene therapy, drug discovery, and sustainable agriculture, driven by innovations in artificial intelligence and data analytics.

Global Genomics Market Dynamics

The key market dynamics that are shaping the Genomics Market include:

Key Market Drivers:

Rising Demand for Personalized Medicine:

The increasing adoption of personalized medicine, which tailors treatments based on individual genetic profiles, is a major driver. According to the U.S. National Institutes of Health, approximately 39% of medicines approved in 2022 were personalized therapies.

Technological Advancements in Genomic Sequencing:

Continuous innovations in sequencing technologies, such as next-generation sequencing (NGS), have significantly reduced the cost of genome sequencing. The National Human Genome Research Institute reported that the cost of sequencing a human genome dropped from $100 million in 2001 to below $1,000 in 2022.

Government Funding and Research Initiatives:

Governments worldwide are investing in genomic research. For instance, the U.S. government allocated $600 million to the National Human Genome Research Institute in 2023 to support advancements in genomics research.

Increasing Prevalence of Genetic Disorders:

The rise in genetic diseases and disorders, such as cancer and rare diseases, is driving demand for genomic research. The World Health Organization (WHO) states that around 10% of all births are affected by genetic or partially genetic conditions, fueling the need for genomic diagnostics and therapies.

Key Challenges:

High Cost of Genomic Technologies:

Despite advancements, the cost of advanced genomic technologies like whole genome sequencing and data analysis remains high, limiting accessibility, especially in low- and middle-income countries.

Data Privacy and Ethical Concerns:

The storage and sharing of sensitive genetic information raise concerns about privacy and misuse, with potential risks of discrimination or unauthorized access to personal health data.

Complexity of Genomic Data Interpretation:

The sheer volume and complexity of genomic data present challenges in accurately interpreting findings, requiring advanced computational tools and specialized expertise, which are not widely available.

Regulatory and Standardization Issues:

The global genomics market faces varying regulatory frameworks across different regions, and the lack of standardized protocols can delay the adoption of genomic technologies in clinical and research settings.

Key Trends:

Integration of Artificial Intelligence (AI) and Machine Learning:

AI and machine learning are increasingly being used to analyze vast amounts of genomic data, improving accuracy and speeding up discoveries in areas like disease diagnosis and drug development.

Expansion of Direct-to-Consumer Genomics:

The rise of companies offering direct-to-consumer genomic testing has empowered individuals to access their genetic information for health, ancestry, and wellness purposes, driving public interest in genomics.

Growth of Precision Medicine Initiatives:

Governments and healthcare systems are focusing more on precision medicine, using genomics to develop personalized treatments tailored to the genetic profiles of individual patients, especially in cancer care.

CRISPR and Gene Editing Advancements:

Gene editing technologies, especially CRISPR, are transforming the genomics landscape by offering tools to modify genes with precision, opening new possibilities in gene therapy, agriculture, and biotechnology.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Genomics Market Regional Analysis

Here is a more detailed regional analysis of the global genomics market:

North America

North America holds the dominant position in the global genomics market, driven by advanced healthcare infrastructure, significant research funding, and a high adoption rate of genomics technologies. The United States, in particular, plays a key role in the region's dominance, with the National Institutes of Health (NIH) allocating over $1.2 billion annually to genomics research. The strong presence of major biotechnology companies and well-established genomic databases further boosts the region's leadership. Moreover, favorable regulatory frameworks and government initiatives like the Precision Medicine Initiative have spurred the growth of personalized genomics in healthcare and research.

The region's robust research environment and cutting-edge technology adoption continue to enhance the genomics market's growth. North America's substantial market share is also attributed to increasing investments in genomic data analysis tools, next-generation sequencing (NGS) technologies, and bioinformatics. As genomics plays a critical role in cancer research, genetic testing, and pharmaceutical development, the region is well-positioned to remain a global leader. The rise in genetic disorder cases and the growing use of genomics in drug development further solidify North America's dominance.

Asia Pacific

Asia Pacific is the fastest-growing region in the global genomics market, fueled by rapid advancements in healthcare infrastructure, government initiatives, and increased investments in research and development. Countries like China, Japan, and India are driving this growth, with China alone projected to see a 12.5% annual growth rate in genomics investments by 2026. The rising awareness of genetic testing and precision medicine, along with the increasing prevalence of chronic diseases, is boosting the demand for genomics-based solutions in the region.

Moreover, government-backed genomics programs like China's Precision Medicine Initiative, which has allocated $9 billion for research, are accelerating the development of genomics in healthcare. In India, the government's Genome India Project aims to map the genetic diversity of over 10,000 individuals, further highlighting the region's focus on genomics research. The growing number of collaborations between local research institutions and global biotechnology companies is also propelling market growth in Asia Pacific, making it a key player in the future of genomics.

Global Genomics Market: Segmentation Analysis

The Global Genomics Market is segmented on the basis of By Technology, By Application, By Product and Services and By Geography.

Genomics Market, By Technology

Sequencing Technologies
Microarray Analysis
PCR
CRISPR

Based on Technology, the Global Genomics Market is segmented into Sequencing Technologies, Microarray Analysis, PCR, and CRISPR. PCR (polymerase chain reaction), and CRISPR, sequencing technologies are dominating the genomics market due to their widespread application in clinical diagnostics, personalized medicine, and large-scale genomic projects. These technologies, especially next-generation sequencing (NGS), provide comprehensive genetic information with high accuracy. On the other hand, CRISPR is the fastest-growing segment, driven by its revolutionary potential in gene editing, gene therapy, and biotechnology, allowing precise modification of DNA sequences, which is transforming research and therapeutic applications across industries.

Genomics Market, By Application

Diagnostics
Drug Discovery and Development
Research
Agriculture And Livestock
Consumer Genomics

Based on Application, the Global Genomics Market is segmented into Diagnostics, Drug Discovery and Development, Research, Agriculture and Livestock, and Consumer Genomics. The Diagnostics segment is dominating the global genomics market, driven by the increasing demand for genetic testing and screening for diseases like cancer and rare genetic disorders. The widespread application of genomic diagnostics in personalized medicine and healthcare systems makes it the leading segment. However, Consumer Genomics is the fastest-growing segment, fueled by the rising popularity of direct-to-consumer genetic testing kits that provide insights into ancestry, health risks, and wellness. The accessibility of these services, along with growing consumer interest in genetic health information, is accelerating its rapid expansion.

Genomics Market, By Products And Services

Instruments And Equipment
Consumables
Software and Services

Based on Product and Services, the Global Genomics Market is segmented into Instruments and Equipment, Consumables, and Software and Services. The Consumables segment dominates due to the recurring demand for reagents, kits, and other supplies required in sequencing and genetic analysis. These consumables are essential for conducting research and diagnostics, driving their consistent use across laboratories, clinics, and research institutions. Meanwhile, the Software and Services segment is the fastest-growing, fueled by the increasing need for advanced data analysis tools to handle large genomic datasets and the rising adoption of cloud-based solutions, bioinformatics, and AI-driven platforms for personalized medicine and research applications.

Genomics Market, By Geography

North America
Europe
Asia Pacific
Rest of the World

Based on the Geography, the Global Genomics Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America holds the dominant position in the global genomics market, driven by advanced healthcare infrastructure, significant research funding, and a high adoption rate of genomics technologies. Asia Pacific is the fastest-growing region in the global genomics market, fueled by rapid advancements in healthcare infrastructure, government initiatives, and increased investments in research and development.

Key Players

The "Global Genomics Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
llumina, Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation (Beckman Coulter), PerkinElmer, QIAGEN, BGI Group, Macrogen, and Oxford Nanopore Technologies.
Our
market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Genomics Market Recent Developments:
In August 2023 Thermo Fisher Scientific completed the acquisition of The Binding Site Group, a leader in specialty diagnostics for blood cancer. This acquisition expands Thermo Fisher's genomics portfolio, enhancing its capabilities in clinical diagnostics and furthering its presence in personalized medicine.
In July 2023 BGI Group, a leading genomics company, launched its latest high-throughput sequencing technology, "DNBSEQ-T7." This platform offers unprecedented speed and accuracy in genome sequencing, enabling more precise data for use in medical research and clinical applications.
In June 2023 Roche announced a collaboration with its subsidiary Genentech to expand cancer genomics research. The partnership focuses on utilizing genomic data to develop targeted therapies for cancer patients, aiming to improve personalized treatment plans through comprehensive genetic profiling.

1 INTRODUCTION OF GLOBAL GENOMICS MARKET

1.1 Introduction of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL GENOMICS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL GENOMICS MARKET, BY TECHNOLOGY

5.1 Overview
5.2 Sequencing Technologies
5.3 Microarray Analysis
5.4 PCR
5.5 CRISPR

6 GLOBAL GENOMICS MARKET, BY APPLICATION

6.1 Overview
6.2 Diagnostics
6.3 Drug Discovery and Development
6.4 Research
6.5 Agriculture And Livestock
6.6 Consumer Genomics

7 GLOBAL GENOMICS MARKET, BY PRODUCT AND SERVICES

7.1 Overview
7.2 Instruments And Equipment
7.3 Consumables
7.4 Software and Services

8 GLOBAL GENOMICS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL GENOMICS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Share
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 llumina
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Thermo Fisher Scientific
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Agilent Technologies
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 , Danaher Corporation (Beckman Coulter)
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 PerkinElmer
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 QIAGEN
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 BGI Group
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 Macrogen
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Oxford Nanopore Technologies
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments